πŸ‡ΊπŸ‡Έ FDA
Patent

US 8344135

Heterocyclic compound and use thereof

granted A61PA61P35/00A61P43/00

Quick answer

US patent 8344135 (Heterocyclic compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P35/00, A61P43/00